Hormone Replacement Therapy Market - Top Companies and Manufacturers

Companies Dominating the Hormone Replacement Therapy Landscape

AbbVie Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Abbott Laboratories
Novo Nordisk A/S
Genentech, Inc.
Novartis AG
F. Hoffmann-La Roche Ltd
Merck KGaA
Mylan N.V.
Bayer AG
Eli Lilly and Company

Browse Key Market Insights with Data Illustration:

Hormone Replacement Therapy Market Size & Share, Growth Trends 2037

In the News

Orion Pharma AB to acquire the clearance for darolutamide indication in the combination with docetaxel from U.S. Food and Drug Administration (FDA). The product is developed for the treatment of metastatic hormone-sensitive prostate cancer shortly known as (mHSPC).
Genentech, Inc. to release positive results from the Phase III SKYSCRAPER-01 study. The study was being conducted to monitor the anti-TIGIT immunotherapy tiragolumab plus Tecentriq (atezolizumab) vs Tecentriq alone as an initial (first-line) to find the cure for people living with advanced or metastatic non-small cell lung cancer (NSCLC).

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of hormone replacement therapy is evaluated at USD 39.62 billion.

The hormone replacement therapy market size was valued at USD 37.29 billion in 2024 and is expected to reach USD 98.63 billion by the end of 2037, expanding at around 7.7% CAGR during the forecast period i.e., between 2025-2037. Higher number of women hitting menopause and growing cases of anxiety disorders will drive the market growth.

North America industry is anticipated to hold majority revenue share by 2037, propelled by significant growth in the geriatric population along with the significant presence of a well-structured healthcare infrastructure in the region.

The major players in the market include AbbVie Inc., Abbott Laboratories, Novo Nordisk A/S, Genentech, Inc., Novartis AG, F. Hoffmann-La Roche Ltd, Merck KGaA, Mylan N.V., Bayer AG, Eli Lilly and Company.

Hormone Replacement Therapy Market - Top Companies and Manufacturers

Companies Dominating the Hormone Replacement Therapy Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the hormone replacement therapy market?

What are the factors driving the hormone replacement therapy landscape?

Which region held the largest hormone replacement therapy industry share?

Who are the key players in the hormone replacement therapy sector?